News Release

Calcium supplements associated with decreased risk of large bowel polyps

Peer-Reviewed Publication

Journal of the National Cancer Institute

Taking calcium supplements is associated with a decreased risk of advanced colon polyps, according to a new study published in the June 16 issue of the Journal of the National Cancer Institute.

Although high calcium intake has been shown to inhibit colon cancer in animal experiments, these effects have not been seen consistently in human studies. In addition, the few studies that have demonstrated an association between calcium intake and moderate decreases in the risk of precancerous colorectal tumors have rarely evaluated the effect of calcium on different types of colorectal lesions or how other aspects of diet may alter the effects of calcium.

To explore in greater detail the chemopreventive effects of calcium supplementation, Kristin Wallace, M.S., and John A. Baron, M.D., of the Dartmouth Medical School in Lebanon, N.H., and colleagues analyzed data from 913 patients enrolled in the Calcium Polyp Prevention Study, a randomized, double-blind, placebo-controlled trial. Patients took either a 1200 mg calcium supplement or a placebo and had a follow-up colonoscopy 1 and 4 years after enrolling in the trial.

Supplemental calcium slightly decreased the risk of all types of colorectal polyps. The effect was greatest for the advanced lesions that are felt to be most strongly associated with invasive colorectal cancer. In addition, there was some evidence that a diet high in fiber and low in fat increased the preventive effect of calcium, but these results were not statistically definitive.

These findings "suggest that total calcium intakes above 1200 mg are necessary, and perhaps that high dietary fiber and modest dietary fat are required to optimize this [anticancer] effect. Additional data regarding nutrient interactions with calcium will help further refine optimum cancer protective strategies and may clarify the mechanisms by which calcium has its effects in the large bowel," the authors write.

In an editorial, Arthur Schatzkin, M.D., Dr.P.H., and Ulrike Peters, Ph.D., of the National Cancer Institute in Bethesda, Md., caution that this study does not yet prove that a causal relation between calcium intake and colorectal cancer exists. However, they write, "studies are now in place with the potential to provide a compelling--almost proven--case that a nutritional factor (calcium) can alter the occurrence of malignant disease (colorectal cancer). That would be a tremendous advance."

###

Contacts:

  • Article: Deborah Kimbell, Dartmouth Medical School, 603-653-1913, Deborah.Kimbell@dartmouth.edu
  • Editorial: National Cancer Institute Press Office, 301-496-6641, ncipressofficers@mail.nih.gov

    Citations:

  • Article: Wallace K, Baron JA, Cole BF, Sandler RS, Karagas MR, Beach MA, et al. Effect of Calcium Supplementation on the Risk of Large Bowel Polyps. J Natl Cancer Inst 2004;96:921-5.
  • Editorial: Schatzkin A, Peters U. Advancing the Calcium–Colorectal Cancer Hypothesis. J Natl Cancer Inst 2004;96:893-4.

    Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oupjournals.org/.


  • Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.